Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation.
作者信息
Chen Chen, Gao Haoming, Guo Xiuli, Wei Wei
机构信息
Department of Ophthalmology, Dalian Women and Children's Medical Group, Dalian, Liaoning Province, China.
People's Liberation Army 32183 Troops Hospital, Baicheng, Jilin Province, China.
出版信息
Eye (Lond). 2025 Apr;39(6):1229. doi: 10.1038/s41433-025-03680-x. Epub 2025 Mar 5.
Abstract
摘要
相似文献
1
Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation.增强对视网膜血管疾病中抗血管内皮生长因子治疗失败的理解：呼吁进行扩展分析和阈值验证。
Eye (Lond). 2025 Apr;39(6):1229. doi: 10.1038/s41433-025-03680-x. Epub 2025 Mar 5.
2
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation.致编辑的信：关于增强对视网膜血管疾病中抗血管内皮生长因子治疗失败的理解：呼吁进行扩展分析和阈值验证。
Eye (Lond). 2025 Apr;39(6):1227-1228. doi: 10.1038/s41433-025-03681-w. Epub 2025 Feb 19.
3
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿：一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
4
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子（VEGF）药物。
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD009734. doi: 10.1002/14651858.CD009734.pub3.
5
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.抗血管内皮生长因子治疗视网膜中央静脉阻塞继发的黄斑水肿
Cochrane Database Syst Rev. 2010 Oct 6(10):CD007325. doi: 10.1002/14651858.CD007325.pub2.
6
Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.抗血管内皮生长因子用于病理性近视患者脉络膜新生血管化的治疗
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD011160. doi: 10.1002/14651858.CD011160.pub2.
7
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较：一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
9
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子（VEGF）药物。
Cochrane Database Syst Rev. 2016;2:CD009734. doi: 10.1002/14651858.CD009734.pub2. Epub 2016 Feb 27.
10
Anti-VEGF Therapy for Retinal Vein Occlusions.视网膜静脉阻塞的抗血管内皮生长因子治疗
Curr Drug Targets. 2016;17(3):328-36. doi: 10.2174/1573399811666150615151324.
本文引用的文献
1
Visual and anatomical failure of anti-VEGF therapy for retinal vascular diseases: a survival analysis of real-world data.抗VEGF治疗视网膜血管疾病的视觉和解剖学失败：真实世界数据的生存分析
Eye (Lond). 2025 Apr;39(5):977-985. doi: 10.1038/s41433-024-03529-9. Epub 2024 Dec 10.
2
Arterial hypertension and retinal layer thickness: the Beijing Eye Study.动脉高血压与视网膜层厚度：北京眼研究。
Br J Ophthalmol. 2023 Dec 18;108(1):105-111. doi: 10.1136/bjo-2022-322229.
3
Interventions to increase attendance for diabetic retinopathy screening.提高糖尿病视网膜病变筛查参与率的干预措施。
Cochrane Database Syst Rev. 2018 Jan 15;1(1):CD012054. doi: 10.1002/14651858.CD012054.pub2.
Zotero 插件